Clinical Trials in Houston

Showing 8181-8200 of 13,620 trials

Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid Tumors

NCT02380677

A Phase 1/2a, open-label, dose-escalation study with enrollment in Phase 1 to continue until determination of the Maximum Tolerated Dose (MTD) /Recommended Phase 2a Dose (RP2D), and then enrollment into Phase 2a expansion cohorts will be initiated.

Advanced Solid Tumor Malignancy

NewLink Genetics Corporation42 participantsStarted Apr 2015

Chapel Hill, North Carolina, United States • Philadelphia, Pennsylvania, United States • Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

NCT00304031

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving radiation therapy together with temozolomide may kill more tumor cells. It is not yet known which schedule of temozolomide when given together with radiation therapy is more effective in treating glioblastoma or gliosarcoma. PURPOSE: This randomized phase III trial is studying two different schedules of temozolomide to compare how well they work when given together with radiation therapy in treating patients with newly diagnosed glioblastoma or gliosarcoma.

Brain and Central Nervous System Tumors

Radiation Therapy Oncology Group1,173 participantsStarted Jan 2006

Fairbanks, Alaska, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +348 more locations

Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid Tumors

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Find Trials by Condition in Houston

Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)

Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger

A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Survey of Cancer Patients' Perceptions of Difficulties Encountered When Filling Opioid Prescriptions

Immunotherapy Study for Surgically Resected Pancreatic Cancer

Transvenous Lead Removal Post-Market Clinical Study

Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder

LEVANT 2 Safety Registry

Dose-Ranging Study of the Bimatoprost Ocular Insert

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

INdividualized ITI Based on Fviii(ATE) Protection by VWF

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes

Comparing the ADR With Air Insufflation, Water Immersion and Water Exchange During Two-endoscopist Colonoscopy